UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Learn the long-term average annual return for index funds and how it informs portfolio construction, diversification, and risk management.
27,739 articlesThree clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Pi Network remains locked in a narrow trading channel around 17 cents, with key support at 16 cents and resistance ne...
When headlines shout about a stalled housing bill, borrowers can feel exposed. This article breaks down what the stal...
XRP is testing critical levels near $1.40 this week as traders watch for a breakout. Momentum is building, but regula...
Solana surged 13% last week, its strongest performance of 2026, driven by ETF demand and higher futures activity. Tra...
XRP and ETH traders are driving a surge in fear of missing out, lifting sentiment to multi-week highs even as prices ...
ECL, EMN, and BCC report mixed quarters as 2026 guidance and cost actions set the tone for a volatile chemicals secto...
Ethereum slides to its yearly low against Bitcoin as traders move ETH to exchanges, signaling rising selling pressure...
Bitcoin cooled after a short burst higher, while Ethereum retraced from a six-week peak. The market posture remains c...
PI traders faced renewed selling pressure this week, driving PI below key thresholds. The market now tests 0.15 suppo...
NVIDIA hits fresh highs after U.S. regulators approve more H200 chip sales to China, lifting momentum across the AI c...
Benchmark lowered its Bakkt price target by about 47%, arguing that near-term monetization remains elusive as the com...